Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca2+ level and contraction in vascular smooth muscle. 1993

S Takizawa, and M Hori, and H Ozaki, and H Karaki
Department of Veterinary Pharmacology, Faculty of Agriculture, University of Tokyo, Japan.

The effects of isoquinoline derivatives, HA1077 (1-[5-isoquinolinesulfonyl]-homopiperazine) and H-7 (1-[5-isoquinolinesulfonyl]-2-methylpiperazine), on cytosolic Ca2+ levels ([Ca2+]i) and muscle tension were examined in vascular smooth muscle of rat aorta. High K+ (72.7 mM) and norepinephrine (1 microM) induced a sustained contraction with a sustained increase in [Ca2+]i. HA1077 and H-7 (3-10 microM) inhibited the increase in muscle tension more strongly than the increase in [Ca2+]i. Verapamil (10 microM) completely inhibited the increase in [Ca2+]i and the contraction induced by high K+ whereas it inhibited the increase in [Ca2+]i more strongly than the contraction due to norepinephrine. The verapamil-insensitive portion of the norepinephrine-induced contraction was inhibited by HA1077 or H-7. In Ca(2+)-free solution, 0.1 microM norepinephrine induced a transient increase in [Ca2+]i and muscle tension. The transient contraction was inhibited by 10 microM HA1077 or 10 microM H-7 without inhibiting the increase in [Ca2+]i. 12-Deoxyphorbol 13-isobutyrate (DPB) (1 microM) caused a sustained contraction, and this contraction was inhibited by HA1077 and H-7 at similar concentrations needed to inhibit the contractions induced by high K+ or norepinephrine. In rabbit mesenteric artery permeabilized with Staphylococcus aureus alpha-toxin, 100 microM HA1077 and 100 microM H-7 inhibited the contraction induced by 0.3 microM Ca2+. These results suggest that the inhibitory effects of isoquinoline derivatives, HA1077 and H-7, are due to a decrease in [Ca2+]i and in the Ca2+ sensitivity of contractile elements in vascular smooth muscle.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010703 Phorbol Esters Tumor-promoting compounds obtained from CROTON OIL (Croton tiglium). Some of these are used in cell biological experiments as activators of protein kinase C. Phorbol Diester,Phorbol Ester,Phorbol Diesters,Diester, Phorbol,Diesters, Phorbol,Ester, Phorbol,Esters, Phorbol
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus

Related Publications

S Takizawa, and M Hori, and H Ozaki, and H Karaki
January 1998, Japanese journal of pharmacology,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
March 1993, European journal of pharmacology,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
January 1991, Japanese journal of pharmacology,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
June 1989, The Journal of pharmacology and experimental therapeutics,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
May 1990, The American journal of physiology,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
October 1988, Naunyn-Schmiedeberg's archives of pharmacology,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
July 2004, Trends in pharmacological sciences,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
January 1991, British journal of pharmacology,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
October 2018, International journal of molecular sciences,
S Takizawa, and M Hori, and H Ozaki, and H Karaki
December 1992, European journal of pharmacology,
Copied contents to your clipboard!